Epilepsy

What is epilepsy?

Epilepsy, also referred to as “seizure disorders”, is a chronic disorder characterised by recurrent, unprovoked seizuresbrief episodes of involuntary movement). Seizures can involve a part of the body (known as a partial or localised seizure) or the entire body (known as a generalised seizure). They are sometimes accompanied by loss of consciousness and control of bowel or bladder function. Seizure episodes are a result of excessive electrical discharges in a group of brain cells which can occur in different brain sites. Seizures can range in severity from the briefest lapses of attention or muscle jerks to severe and prolonged convulsions. They can also vary in frequency, from less than 1 per year to several per day2. Many people with epilepsy have more than one type of seizure and may have symptoms of other neurological problems as well1.   

Epilepsy is the fourth most common neurological disorder and affects people of all ages1. Approximately 50 million people worldwide have epilepsy and nearly 80% live in low and middle-income countries. People with epilepsy respond to treatments approximately 70% of the time2

What types of medicines are available for epilepsy?

Check out the medicines we are able to source and deliver to patients by selecting specific disease pages below.

If a medicine has been approved by at least one reputable medical authority in the world but it is not available in your country, you may be able to source and deliver it to you if you can provide a prescription from your doctor. 


References 

1. What is Epilepsy?
    Epilepsy Foundation, cited on Feb 2018.

2. Epilepsy Fact Sheet
    World Health Organisation (WHO), Feb 2018.

  1. Fycompa (perampanel)
    Fycompa (perampanel)
    by Eisai Europe Ltd
    for Epilepsy
    €15.80
View as Grid List

1 Item

per page
Set Descending Direction

One more step before you can continue

Our service contains information about acquiring medicines that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

Scroll down.

No, I'd like to receive general information only.

Disclaimer: The information TSM provides is aimed at patients with terminal and life-debilitating diseases, their doctors and healthcare professionals. It supports an informed decision by the treating doctor about the patient’s treatment and the consideration of a medicine which has not been approved in the patient’s country.